Introduction
============

Hospitalization rates for ulcerative colitis (UC) are increasing.^[@bib1],\ [@bib2]^ In this era of value-based medicine, it is important to identify factors that decrease health-care resource utilization and mortality while maintaining good outcomes. Currently, it is not known whether the timing of endoscopic evaluation during hospitalization impacts hospital outcomes in patients with UC-related admissions. Many experts recommend performing a flexible sigmoidoscopy or colonoscopy as soon as possible or within 72 h to assess the endoscopic severity and differentiate overlapping diagnoses such as *Clostridium difficile* (*C. difficile*) colitis and cytomegalovirus (CMV) colitis.^[@bib3],\ [@bib4]^ Whereas, some experts suggest that endoscopy may be more appropriate after the response to steroids has been measured, typically on or after day 3 of hospitalization.^[@bib3]^

To help clinicians understand the differences in health-care outcomes between early and delayed endoscopy, we studied the in-hospital mortality, length of hospital stay (LOS), hospital cost, and frequency of large intestine surgery among patients with UC-related hospitalizations in relation to the timing of endoscopy performance.

Methods
=======

Data source
-----------

Data were extracted from the National Inpatient Sample (NIS) between 2006 and 2013. The NIS is maintained as part of the Healthcare Cost and Utilization Project sponsored by the Agency for Healthcare Research and Quality. This is the largest all-payer inpatient care database in the United States.^[@bib5]^ This database reflects a 20% sample of nonfederal, acute-care hospitals in the United States. Each data entry includes a unique identifier, demographic variables (including age, gender, and race/ethnicity), type of admission (emergent, urgent, or elective), source of admission (emergency room, another hospital, or long-term facility), day of admission (weekend or weekdays), primary and secondary diagnoses (up to 25), primary and secondary procedures (up to 15), primary insurance payers, hospital cost, and LOS.^[@bib6]^

The Ohio State Data and Specimen Policy and Human Subjects Research policy does not require Institutional Review Board approval for population-based public data set. The data contained within the data set are neither identifiable nor private and do not meet the federal definition of "human subject" as expressed in 45 Code of Federal Regulations (CFR 46.101).

Study population, definition of variables, and outcomes
-------------------------------------------------------

Our study population consisted of all adult discharges aged 19 years or older of UC-related hospitalizations. UC-related hospitalizations were selected using appropriate International Classification of Diseases, Ninth revision, Clinical modification codes (ICD-9-CM) ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}). The discharges were considered to be UC-related if they had a principle diagnosis of UC. These criteria have been used previously.^[@bib7]^

Endoscopic procedures included flexible sigmoidoscopy, rigid sigmoidoscopy, and colonoscopy according to the appropriate ICD-9-CM codes ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}).^[@bib8]^ We classified the timing of endoscopy as early if the endoscopy occurred within 2 days of hospitalization and delayed if the endoscopy occurred between the third day and the seventh day of hospitalization. If patients had undergone two endoscopies during the same hospitalizations, only the day of the first endoscopy was used.

Patient variables included age, gender, race, and insurance status. Race was categorized as White, Black, Hispanic, and other. Insurance status was categorized as Medicare, Medicaid, Private, and other based on the primary payer listed on the discharge record. Comorbidities for risk adjustment were derived from the Agency for Healthcare Research and Quality comorbidity measures using the Elixhauser score, a widely used and validated measure of comorbidity in hospitalized patients.^[@bib9]^ The comorbidity burden was stratified based on the presence of \<3 comorbidities as reference vs. ≥3 comorbidities. Hospital variables included bed size, type, inflammatory bowel disease (IBD) admission volume, and admission day. Hospital bed size was classified as small, medium, or large. Hospital type was categorized as rural, urban non-teaching, and urban teaching. IBD admission volume was classified as low-volume (1--50 hospitalizations), medium-volume (50--150 hospitalizations), and high-volume (more than 150 hospitalizations) hospitals depending on their annual volume of IBD-related hospitalizations as described and validated in a previous study.^[@bib5]^

UC-specific severity scores were calculated on the basis of the presence of certain complications such as anemia, malnutrition, requirement for blood transfusion, or total parenteral nutrition ([Supplementary Table 2a](#sup1){ref-type="supplementary-material"}).^[@bib10]^ The scores ranged from 0 to 7 with higher scores representing greater severity of disease, and thus a higher likelihood of colectomy. The disease-specific severity score has been shown to predict the outcome of interest in derivation and validation cohorts from the NIS and could be used to stratify hospitalizations into low, intermediate, and high severity strata.^[@bib10],\ [@bib11]^

Coexisting CMV infection^[@bib12],\ [@bib13],\ [@bib14],\ [@bib15],\ [@bib16]^ can indicate or trigger severe inflammation in UC patients and is associated with worse outcomes. Baseline characteristics of all patients included the status of CMV infection.

The primary outcomes were in-hospital mortality, frequency of large intestine surgery, LOS, and hospital cost. The latter two are collectively referred to as health-care resource utilization.

Exclusions
----------

Patients who were younger than 19 years old, carried diagnoses of both Crohn\'s disease and UC, were electively admitted, had coexisting *C. difficile* infection, or were transferred from other hospitals were excluded.

Validity of ICD-9-CM coding in two tertiary referral hospitals
--------------------------------------------------------------

To validate the accuracy of the ICD-9-CM codes for UC, 154 charts with UC as the principle discharge diagnosis (date range 2011--2014) in the Ohio State University affiliated hospitals were reviewed using clinical, pathological, and radiological findings. This study has been approved by the institutional review board of the Ohio State University Medical Center. One hundred forty four patients with principle discharge ICD-9-CM codes of UC (93.5%) presented with symptoms of acute flare of UC on admission.

Statistical analysis
--------------------

SAS 9.4 (SAS Institute, Cary, NC) was used to perform all analyses, employing appropriate survey estimation commands and strata weights. Categorical variables were tested for statistical significance with *χ*^2^ tests, whereas differences in continuous variables were analyzed with *t*-test. Statistical significance was defined by *P*\<0.05. Linear regression was used to evaluate the effect of timing of endoscopies on LOS and hospital cost and logistic regression was used to calculate odds ratios (OR) and corresponding 95% confidence intervals (CI) for in-hospital mortality and large intestine surgery. Multivariate regression models adjusted for variables significantly associated with endoscopy timing at *P*≤0.1 on univariate analysis.

Results
=======

Patient characteristics
-----------------------

Of the 84,359 patients with UC-related hospitalizations during the study period, 67.2% (56,657) underwent an early endoscopy and 32.8% (27,702) underwent a delayed endoscopy ([Table 1](#tbl1){ref-type="table"}). There were 16,537 patients excluded. The patients who underwent an early endoscopy were younger (45.89 vs. 48.57, *P*\<0.001), had less severe disease (72.80% vs. 66.54%, *P*\<0.001), fewer comorbidities (69.46% vs. 58.83%, *P*\<0.001), and were less likely to have CMV infection (0.37% vs. 0.62%, *P*=0.033), compared with the patients in the delayed group. There were also significant differences in sex (*P*\<0.001), race (*P*\<0.001), insurances types (*P*\<0.001), admission day (*P*\<0.001), IBD admission volume (*P*=0.03), and hospital type (*P*\<0.001) ([Table 1](#tbl1){ref-type="table"}).

Severity score analysis
-----------------------

UC-specific severity scores were calculated to stratify patients into low, intermediate, and high severity groups. Univariate analysis of the conditions that comprise the severity score revealed that there were statistically significant differences in anemia (*P*\<0.001), blood transfusion (*P*\<0.001), malnutrition (*P*\<0.001), parenteral nutrition (*P*\<0.001), and admission to teaching hospitals (*P*\<0.001) across the two cohorts, with the delayed endoscopy group having the higher percentage of patients with those characteristics ([Supplementary Table 2a--b](#sup1){ref-type="supplementary-material"}).

Outcomes
--------

### In-hospital mortality

Multivariate analysis was performed to compare patients with UC-related hospitalization who underwent early and delayed endoscopies and was stratified by disease severity ([Table 2](#tbl2){ref-type="table"}). After we adjusted for all variables in [Table 1](#tbl1){ref-type="table"} with *P*≤0.1 on the univariate analysis, patients in the delayed endoscopy group had higher mortality overall compared with the early endoscopy group (adjusted OR: 1.76 (95% CI: 1.08, 2.88)). The mortality benefits of early endoscopy were mainly seen in the intermediate severity strata (adjusted OR: 2.39 (95% CI: 1.15, 4.96)).

### Length of stay (LOS)

Multivariate analysis was performed to evaluate the difference in LOS among these two cohorts after adjusting for all variables in [Table 1](#tbl1){ref-type="table"} with *P*≤0.1 on univariate analysis ([Table 3](#tbl3){ref-type="table"}). Overall, the delayed endoscopy group had about 3 days longer in LOS compared with the early endoscopy group (adjusted coefficient: 2.69 (95% CI: 2.61, 2.77) *P*\<0.001). The findings were consistent across the low, intermediate, and high severity strata (*P*\<0.001) ([Table 3](#tbl3){ref-type="table"}).

### Hospital cost

Similarly, multivariate analysis of hospital cost demonstrated that patients in the delayed endoscopy group incurred significantly higher hospital cost compared with the early endoscopy group (adjusted coefficient: \$3,394 (95% CI: 3,234, 3,554) *P*\<0.001). The findings were unchanged across the low, intermediate, and high severity strata (*P*\<0.001) ([Table 4](#tbl4){ref-type="table"}).

### Large intestine surgery

Multivariate analysis of frequency of large intestine surgery demonstrated that overall the frequency of large intestine surgery was similar between the delayed and early endoscopy groups. However, in the intermediate severity strata, delayed endoscopy was associated with higher odds of large intestine surgery (adjusted OR: 1.60 (95% CI: 1.01, 2.53)) ([Table 5](#tbl5){ref-type="table"}).

Discussion
==========

In this study, for patients with UC-related hospitalization, we have demonstrated that early sigmoidoscopy or colonoscopy, defined as endoscopy within the first 2 days of hospitalization, was associated with favorable hospital outcomes including decreased in-hospital mortality, lesser hospital cost, and shorter LOS compared with delayed endoscopy. To our knowledge, this is the first study of this magnitude to demonstrate favorable clinical outcomes that are independently associated with the timing of endoscopy.

The benefits of endoscopy in UC-related hospitalizations include the assessment of endoscopic severity, evaluating for infections such as CMV infections, and other conditions that could mimic UC, such as ischemic colitis. In addition, the findings of endoscopy might also prompt the early decision of using rescue medical therapy, such biological therapy. The degree of endoscopic activity may also predict the severity of the disease course.^[@bib3],\ [@bib17]^ Previous studies have shown that clinical outcomes and the need for colectomy were clearly linked to the presence and extent of deep colonic ulcerations. Severe endoscopic lesions were independent predictors for treatment failure.^[@bib18],\ [@bib19]^ Therefore, performing an early endoscopy would enable health-care providers to make timely and appropriate clinical decisions. Early introduction of biological medications and timely surgical consultation have the potential to significantly alter the disease course.

In our study, the overall frequency of large intestine surgery, such as colectomy, was similar between the early and delayed endoscopy groups. However, when patients were stratified into three subgroups on the basis of the disease severity, early endoscopy was associated with less requirement of large intestine surgery in patients with intermediate disease severity. In addition, the mortality benefit of early endoscopy was also mainly seen in the patients with intermediate disease severity. It suggests that the outcomes of UC patients with intermediate disease severity would be more significantly impacted by early endoscopy because the clinical course of these patients is more likely influenced by the implementation of rescue medical therapy on time.

The 2012 consensus statement of the Canadian Association of Gastroenterology recommends an early flexible sigmoidoscopy with biopsies to assess endoscopic severity, *C difficile* infection, or CMV colitis on hospitalized patients with severe UC.^[@bib3]^ They recommend that performing this evaluation at the time of admission would be appropriate. The British Society of Gastroenterology 2011 guidelines advocate for flexible sigmoidoscopy and biopsy within 72 h (ideally within 24 h) of an acute severe UC admission to confirm the diagnosis and exclude CMV.^[@bib4]^ To our knowledge, neither the American College of Gastroenterology nor the American Gastroenterological Association have guidelines or consensus statements that specifically address this question. In our study, 94.3% of patients who received early endoscopy and 93.8% of patient who received delayed endoscopy underwent biopsies. In addition, we also performed an analysis to compare the hospital outcomes of UC patients receiving colonoscopy with those receiving sigmoidoscopy. In the early endoscopy group, colonoscopy was associated with less mortality and hospital cost, shorter LOS, and less frequency of large intestine surgery when compared with sigmoidoscopy. But in the delayed endoscopy group, the outcomes were similar between colonoscopy and sigmoidoscopy ([Supplementary Tables 3a--b](#sup1){ref-type="supplementary-material"}). These findings might be partially due to the bias of endoscopists because patients receiving sigmoidoscopy might have more severe endoscopy findings, which prevent the completion of a full colonoscopy. However, this also suggests that in some patients with UC-related hospitalization, colonoscopy is still a safe procedure to be performed. This large sample-size study will contribute to the existing literature as it supports the recommendations of gastroenterology societies to perform an early endoscopy for patients with UC-related hospitalizations. As a result, it may impact future clinical practice and guidelines on the management of hospitalized UC patients.

Our study had several limitations. An important limitation of this study is that because we used administrative data in the study, the accuracy of ICD-9-CM coding could not be verified by medical charts, owing to privacy safeguards. However, an analysis by the Agency for Healthcare Research and Quality comparing the NIS and other national databases demonstrated good reliability.^[@bib20]^ In addition, misclassification of ICD-9-CM coding should be distributed uniformly and non-differentially across all groups.^[@bib21]^ Furthermore, administrative discharge codes have been widely used and validated for the analysis of various diseases and their outcomes. The discharge codes in our study have been used by several previous studies.^[@bib7],\ [@bib11]^ We have also performed a chart review within our tertiary referral medical centers. Our review revealed that the principle discharge code of UC accurately represented symptoms of acute UC flare on admission (93.5%) in our medical centers. There were probably more patients with steroid-refractory or steroid non-responded IBD in the delayed endoscopy group. In our study, the disease-specific severity was stratified into low, intermediate, and high severity strata on the basis of variables available in the administrative databases. Although the variables did not include detailed clinical or laboratory data, the method of stratification has been previously validated and has been shown to predict the severity of UC-related hospitalization.^[@bib9],\ [@bib10],\ [@bib11]^ In our multivariate models, we adjusted for the status of CMV infection, which was expected to contribute to disease severity in patients with UC.^[@bib12],\ [@bib13],\ [@bib14],\ [@bib15],\ [@bib16]^ Given the structure of the NIS, we could not obtain the information of medication use, laboratory, and endoscopy findings. In our study, the majority of the patients underwent biopsy during endoscopy, suggesting the importance of endoscopy with biopsy in hospitalized UC patients. The hospital outcomes of the subgroup patients who have undergone biopsy during the endoscopy were similar to our main results (data not shown). Because of the cross-sectional design of the study, we could only determine the association between early endoscopy and better outcomes in patients with UC-related hospitalizations. However, to determine causality, a prospective study would be required.

Despite the above limitations, our study also has strengths. The NIS database provides a large number of patients with a discharge diagnosis of UC who have undergone endoscopies, which otherwise would not be possible from smaller single center or multicenter studies. The benefit of using the NIS database is that the results represent the current national inpatient health-care utilization of patients with UC-related hospitalizations.

In conclusion, early colonoscopy or sigmoidoscopy, within 2 days of admission, is associated with improved outcomes in patients with UC-related hospitalizations. Although these findings need to be validated in prospective studies, nevertheless, our study supports the recommendations of gastroenterology societies to perform an early endoscopy for patients with UC-related hospitalizations.^[@bib3],\ [@bib4]^

Study Highlights
================
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###### 

Click here for additional data file.

###### Univariate analysis of demographic and hospital characteristics, and comorbidities among patients with ulcerative colitis-related hospitalizations who underwent early or delayed endoscopy

                                               **\<3 Days to endoscopy (*****n*****=56,657)**   **≥3 Days to endoscopy (27,702)**     ***P*****value**             
  ------------------------------------------- ------------------------------------------------ ----------------------------------- ---------------------- -------- ---------
                                                                                                                                                                        
  Age (mean, CI)[a](#t1-fn2){ref-type="fn"}                 45.89 (45.43, 46.35)                                                    48.57 (47.92, 49.23)            \<0.001
  *Sex*                                                                                                                                                             \<0.001
   Male                                                            27,083                                    47.98%                        12,176          44.02%       
   Female                                                          29,361                                    52.02%                        15,482          55.98%       
                                                                                                                                                                        
  *Race*                                                                                                                                                            \<0.001
   White                                                           37,233                                    71.79%                        17,852          68.81%       
   Black                                                           5,769                                     11.12%                        3,492           13.46%       
   Hispanic                                                        5,965                                     11.50%                        3,158           12.17%       
   Other                                                           2,897                                      5.59%                        1,443           5.56%        
                                                                                                                                                                        
  *Hospital bed size*                                                                                                                                                0.645
   Small                                                           6,716                                     11.92%                        3,137           11.39%       
   Medium                                                          14,312                                    25.39%                        7,065           25.64%       
   Large                                                           35,333                                    62.69%                        17,350          62.97%       
                                                                                                                                                                        
  *Hospital type*                                                                                                                                                   \<0.001
   Rural                                                           4,570                                      8.11%                        2,127           7.72%        
   Urban non-teaching                                              25,510                                    45.26%                        11,426          41.47%       
   Urban teaching                                                  26,280                                    46.63%                        14,000          50.81%       
                                                                                                                                                                        
  *Insurance*                                                                                                                                                       \<0.001
   Medicare                                                        13,662                                    24.16%                        8,248           29.84%       
   Medicaid                                                        6,398                                     11.32%                        3,553           12.85%       
   Private                                                         28,115                                    49.72%                        11,878          42.97%       
   Other                                                           8,366                                     14.80%                        3,962           14.33%       
                                                                                                                                                                        
  *Elixhauser score*                                                                                                                                                \<0.001
   \<3                                                             39,354                                    69.46%                        16,298          58.83%       
   ≥3                                                              17,303                                    30.54%                        11,404          41.17%       
                                                                                                                                                                        
  *IBD admission volume*                                                                                                                                             0.030
   Low (0--50)                                                     41,185                                    72.69%                        19,527          70.49%       
   Medium (51--150)                                                12,378                                    21.85%                        6,373           23.01%       
   High (\>150)                                                    3,094                                      5.46%                        1,802           6.51%        
                                                                                                                                                                        
  *Admission day*                                                                                                                                                   \<0.001
   Weekday                                                         44,898                                    79.25%                        20,913          75.49%       
   Weekend                                                         11,759                                    20.75%                        6,789           24.51%       
                                                                                                                                                                        
  *Severity score*                                                                                                                                                  \<0.001
   Low                                                             41,029                                    72.80%                        18,333          66.54%       
   Intermediate                                                    13,436                                    23.84%                        7,650           27.77%       
   High                                                            1,896                                      3.36%                        1,569           5.69%        
                                                                                                                                                                        
  *CMV*                                                                                                                                                              0.033
   No                                                              56,445                                    99.63%                        27,531          99.38%       
   Yes                                                              211                                       0.37%                         171            0.62%        

Categorical variables were expressed as weighted frequency (percentage) and differences between groups were analyzed by *χ*^2^ tests. Continuous variables were expressed as mean (confidence interval) and differences were analyzed with *t*-tests. Data are numbers and percentages unless otherwise indicated. Percentages may not sum to 100 due to rounding. 2006--2013 were combined for all of the above analyses.

Mean with 95% confidence interval.

###### Multivariate analysis of in-hospital mortality among patients with UC-related hospitalizations who had either early or delayed endoscopy by disease severity

                         **Number of events**[a](#t2-fn3){ref-type="fn"}   **Percentage of total**[a](#t2-fn3){ref-type="fn"}  **Adjusted OR**[b](#t2-fn4){ref-type="fn"}   **95% CI**     ***P*** **value**
  --------------------- ------------------------------------------------- ---------------------------------------------------- -------------------------------------------- -------------- -------------------
  *Overall*                                                                                                                                                                                0.024
   \<3 Days                                    165                                               0.29%                         Reference                                                    
   ≥3 Days                                     207                                               0.75%                         1.76                                         (1.08, 2.88)    
                                                                                                                                                                                            
  *Low severity*                                                                                                                                                                           0.201
   \<3 Days                                    68                                                0.16%                         Reference                                                    
   ≥3 Days                                     70                                                0.38%                         1.65                                         (0.77, 3.57)    
                                                                                                                                                                                            
  *Moderate severity*                                                                                                                                                                      0.020
   \<3 Days                                    63                                                0.46%                         Reference                                                    
   ≥3 Days                                     99                                                1.27%                         2.39                                         (1.15, 4.96)    
                                                                                                                                                                                            
  *High severity*                                                                                                                                                                          0.560
   \<3 Days                                    34                                                1.54%                         Reference                                                    
   ≥3 Days                                     38                                                2.25%                         1.33                                         (0.51, 3.43)    

CI, confidence interval; OR, odds ratio.

2006--2013 were combined for all of the above analyses.

Data are numbers and percentages unless otherwise indicated.

Adjusted for age, sex, race, hospital size, hospital type, insurance, Elixhauser score, IBD admission volume, admission day, severity score, year, and CMV.

###### Multivariate analysis of LOS among patients with UC-related hospitalizations who had either early or delayed endoscopy by disease severity

                        **Days**[a](#t3-fn3){ref-type="fn"}   **AC**[b](#t2-fn4){ref-type="fn"}   **95% CI**      ***P*** **value**
  --------------------- ------------------------------------- ----------------------------------- -------------- -------------------
  *Overall*                                                                                                            \<0.001
   \<3 Days             4.86 (4.78, 4.95)                     Reference                                                    
   ≥3 Days              7.93 (7.78, 8.07)                     2.69                                (2.61, 2.77)             
                                                                                                                           
  *Low severity*                                                                                                       \<0.001
   \<3 Days             4.21 (4.14, 4.28)                     Reference                                                    
   ≥3 Days              6.93 (6.80, 7.05)                     2.59                                (2.53, 2.66)             
                                                                                                                           
  *Moderate severity*                                                                                                  \<0.001
   \<3 Days             5.96 (5.76, 6.15)                     Reference                                                    
   ≥3 Days              8.92 (8.62, 9.22)                     2.83                                (2.45, 3.21)             
                                                                                                                           
  *High severity*                                                                                                      \<0.001
   \<3 Days             10.37 (9.57, 11.16)                   Reference                                                    
   ≥3 Days              13.98 (13.00, 14.96)                  3.49                                (2.29, 4.70)             

AC, adjusted coefficient; CI, confidence interval; LOS, length of stay; UC, ulcerative colitis.

2006--2013 were combined for all of the above analyses.

Mean with 95% confidence interval.

Adjusted for age, sex, race, hospital size, hospital type, insurance, Elixhauser score, IBD admission volume, admission day, severity score, year, and CMV.

###### Multivariate analysis of total hospital cost among patients with UC-related hospitalizations who had either early or delayed endoscopy by disease severity

                        **Cost (\$)**[a](#t4-fn3){ref-type="fn"}   **AC**[b](#t4-fn4){ref-type="fn"}   **95% CI**         ***P*** **value**
  --------------------- ------------------------------------------ ----------------------------------- ----------------- -------------------
  *Overall*                                                                                                                    \<0.001
   \<3 Days             8,912 (8,718, 9,106)                       Reference                                                       
   ≥3 Days              13,031 (12,658, 13,405)                    3,394                               (3,234, 3,554)              
                                                                                                                                   
  *Low severity*                                                                                                               \<0.001
   \<3 Days             7,658 (7,490, 7,825)                       Reference                                                       
   ≥3 Days              10,915 (10,599, 11,231)                    3,024                               (2,888, 3,159)              
                                                                                                                                   
  *Moderate severity*                                                                                                          \<0.001
   \<3 Days             10,997 (10,577, 11,417)                    Reference                                                       
   ≥3 Days              15,047 (14,338, 15,755)                    3,736                               (2,851, 4,621)              
                                                                                                                                   
  *High severity*                                                                                                              \<0.001
   \<3 Days             19,535 (17,610, 21,460)                    Reference                                                       
   ≥3 Days              26,148 (23,546, 28,751)                    6,799                               (3,570, 10,028)             

AC, adjusted coefficient; CI, confidence interval; UC, ulcerative colitis.

2006--2013 were combined for all of the above analyses.

Mean with 95% confidence interval.

Adjusted for age, sex, race, hospital size, hospital type, insurance, Elixhauser score, IBD admission volume, admission day, severity score, year, and CMV.

###### Multivariate analysis of frequency of large intestine surgery among patients with UC-related hospitalizations who had either early or delayed endoscopy by disease severity

                        **Number of events**[a](#t5-fn3){ref-type="fn"}   **Percentage of total**[a](#t5-fn3){ref-type="fn"}   **AOR**[b](#t5-fn4){ref-type="fn"}   **95% CI**      ***P*** **value**
  --------------------- ------------------------------------------------- ---------------------------------------------------- ------------------------------------ -------------- -------------------
  *Overall*                                                                                                                                                                               0.293
   \<3 Days             703                                               1.24%                                                Reference                                                     
   ≥3 Days              510                                               1.84%                                                1.16                                 (0.88, 1.53)             
                                                                                                                                                                                             
  *Low severity*                                                                                                                                                                          0.885
   \<3 Days             306                                               0.74%                                                Reference                                                     
   ≥3 Days              163                                               0.88%                                                0.97                                 (0.62, 1.52)             
                                                                                                                                                                                             
  *Moderate severity*                                                                                                                                                                     0.047
   \<3 Days             215                                               1.56%                                                Reference                                                     
   ≥3 Days              197                                               2.53%                                                1.60                                 (1.01, 2.53)             
                                                                                                                                                                                             
  *High severity*                                                                                                                                                                         0.557
   \<3 Days             182                                               8.31%                                                Reference                                                     
   ≥3 Days              149                                               8.69%                                                0.86                                 (0.52, 1.42)             

AOR, adjusted odds ratio; CI, confidence interval; UC, ulcerative colitis.

2006--2013 were combined for all of the above analyses.

Data are numbers and percentages unless otherwise indicated.

Adjusted for age, sex, race, hospital size, hospital type, insurance, Elixhauser score, IBD admission volume, admission day, severity score, year, and CMV.
